↓ Skip to main content

Dove Medical Press

MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease

Overview of attention for article published in Open Access Journal of Clinical Trials, January 2020
Altmetric Badge

Mentioned by

twitter
5 X users

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
69 Mendeley